Concentrated Investing: Position Size, Risk and Review Rules

Concentrated Investing: Conviction, Position Size and Risk featured image

Concentrated Investing: Position Size, Risk and Review Rules

Short answer: concentration can make an investor’s best ideas matter more, but it also makes analytical, behavioural and financial mistakes more expensive. This is a personal process for thinking about that trade-off, not a model allocation to copy.

For education and information only. This is not personal financial, investment, tax or legal advice, and it is not a recommendation to buy, sell or hold any investment. A concentrated portfolio can lose substantial value.

Why concentration is deliberate, and why it is hazardous

A concentrated portfolio is not automatically more thoughtful than a diversified one. It is simply more exposed to the accuracy of a smaller number of decisions. A business can disappoint, a valuation can compress, a financing can dilute existing holders or several seemingly separate holdings can fail for the same macro reason.

The FCA explains in its diversification guidance that spreading investments can reduce reliance on any one investment performing well. That does not mean diversification eliminates losses, or that a concentrated investor should pretend the risk is not there. It means the trade-off should be visible before capital is committed.

Start with risk capacity, not conviction

  • What cash is needed for emergencies, near-term commitments or debt?
  • How would a severe drawdown affect work, sleep and the ability to make good decisions?
  • Which holdings share a sector, customer, funding or macroeconomic exposure?
  • How liquid is the position if the thesis changes?
  • What would force a sale at the worst possible moment?

There is no universally correct maximum position size. A number that is tolerable for one investor can be reckless for another. The important work is defining a personal initial size, maximum size and conditions for changing either.

My position-sizing framework

  1. Start with the downside. Evidence that is early, weak liquidity, high leverage, external financing needs or correlated exposure all argue for a smaller initial position.
  2. Write the maximum before the outcome. Do not let a rising share price quietly turn a position into a portfolio decision you never chose.
  3. Separate adding from averaging down. A lower price is not evidence that a thesis is stronger. Re-check the original assumptions first.
  4. Keep a do-nothing option. New information does not always require an immediate trade.

Track dilution and capital allocation

For businesses that use shares, options, warrants, convertibles or at-the-market facilities, ownership can change even while the headline business story sounds positive. Track basic and diluted share counts, outstanding awards, future financing needs and whether new capital has a credible route to creating per-share value.

Thesis review and invalidation

Every meaningful position needs a written original thesis, a bear case, observable milestones and specific invalidation conditions. A falling price is not automatically an invalidation event. Deteriorating unit economics, a broken customer relationship, an unexpected financing or a failed operational milestone may matter much more.

Keep a change log. It separates what was known at the time of the decision from the story hindsight wants to tell later.

What I will not claim

Concentration is not safety. Public disclosure of a holding is not an invitation to copy it. Past results do not make the process right. The point of a framework is not to make risk disappear. It is to make the decision, risk and reassessment criteria explicit.

Related reading

Leave a Reply

Your email address will not be published. Required fields are marked *